114 related articles for article (PubMed ID: 37317483)
1. Rosline promotes p21 expression to inhibit ovarian cancer cell proliferation via p53-independent pathway.
Zhao T; Xiao X; Li L; Wu X; Yuan T
J Obstet Gynaecol Res; 2023 Aug; 49(8):2126-2134. PubMed ID: 37317483
[TBL] [Abstract][Full Text] [Related]
2. RNF144B-mediated p21 degradation regulated by HDAC3 contribute to enhancing ovarian cancer growth and metastasis.
Zhuang H; Zhang Z; Wang W; Qu H
Tissue Cell; 2024 Feb; 86():102277. PubMed ID: 37992458
[TBL] [Abstract][Full Text] [Related]
3. CCDC106 promotes the proliferation and invasion of ovarian cancer cells by suppressing p21 transcription through a p53-independent pathway.
Zhao N; Wang C; Guo P; Hou J; Yang H; Lan T; Zhou Y; Li J; Bhawal UK; Liu Y
Bioengineered; 2022 Apr; 13(4):10956-10972. PubMed ID: 35484984
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway.
Liu T; Qin W; Hou L; Huang Y
Tumour Biol; 2015 Mar; 36(3):1881-93. PubMed ID: 25510663
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
6. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer.
Zhang H; Zhang X; Li X; Meng WB; Bai ZT; Rui SZ; Wang ZF; Zhou WC; Jin XD
J Cell Physiol; 2018 Jan; 234(1):619-631. PubMed ID: 30069972
[TBL] [Abstract][Full Text] [Related]
7. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
8. Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21.
Zhu D; Shi C; Jiang Y; Zhu K; Wang X; Feng W
Bioengineered; 2021 Dec; 12(1):1505-1516. PubMed ID: 33944652
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer.
Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z
Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639
[TBL] [Abstract][Full Text] [Related]
10. FOXD1 is targeted by miR-30a-5p and miR-200a-5p and suppresses the proliferation of human ovarian carcinoma cells by promoting p21 expression in a p53-independent manner.
Wang Y; Qiu C; Lu N; Liu Z; Jin C; Sun C; Bu H; Yu H; Dongol S; Kong B
Int J Oncol; 2018 Jun; 52(6):2130-2142. PubMed ID: 29620165
[TBL] [Abstract][Full Text] [Related]
11. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
[TBL] [Abstract][Full Text] [Related]
12. p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.
Zheng F; Tang Q; Wu J; Zhao S; Liang Z; Li L; Wu W; Hann S
J Exp Clin Cancer Res; 2014 Apr; 33(1):36. PubMed ID: 24766860
[TBL] [Abstract][Full Text] [Related]
13. A novel small molecule, Rosline, inhibits growth and induces caspase-dependent apoptosis in human lung cancer cells A549 through a reactive oxygen species-dependent mechanism.
Zhao T; Feng Y; Jin W; Pan H; Li H; Zhao Y
Cell Biol Int; 2016 Jun; 40(6):686-95. PubMed ID: 27006094
[TBL] [Abstract][Full Text] [Related]
14. [Vincristine inhibits the proliferation of ovarian cancer cells by regulating the demethylation of RASSF2A].
Wang WX; Fan WW; Gao YX; Dong XC; Feng XJ; Ren J
Zhonghua Zhong Liu Za Zhi; 2021 Sep; 43(9):932-938. PubMed ID: 34530575
[No Abstract] [Full Text] [Related]
15. The aberrant upstream pathway regulations of CDK1 protein were implicated in the proliferation and apoptosis of ovarian cancer cells.
Zhang R; Shi H; Ren F; Zhang M; Ji P; Wang W; Liu C
J Ovarian Res; 2017 Sep; 10(1):60. PubMed ID: 28899430
[TBL] [Abstract][Full Text] [Related]
16. OTX1 silencing suppresses ovarian cancer progression through inhibiting the JAK/STAT signaling.
Zhang Q; Li X; Ren L; Gu X; Xiao N; Li N
Tissue Cell; 2023 Jun; 82():102082. PubMed ID: 37027968
[TBL] [Abstract][Full Text] [Related]
17. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells.
Luo Y; Yi Y; Yao Z
Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010
[TBL] [Abstract][Full Text] [Related]
18. miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1.
Li C; Wang Y; Wang H; Wang B; Wang Y; Li N; Qin Y; Wang Y
Anal Cell Pathol (Amst); 2021; 2021():7407086. PubMed ID: 34395181
[TBL] [Abstract][Full Text] [Related]
19. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis.
Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X
Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829
[TBL] [Abstract][Full Text] [Related]
20. Anlotinib induces apoptosis and second growth/mitosis phase block in cisplatin-resistant ovarian cancer cells via the aurora kinase A/p53 pathway.
Wang H; Wang Y
Hum Exp Toxicol; 2023; 42():9603271231185774. PubMed ID: 37392187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
